Both medications may help reduce cravings by supporting appetite and fullness signaling
Blocking the receptors in the arcuate nucleus or in the nodose ganglion does not block the effect, she said, so we really need to focus on these hindbrain NST [nucleus of the solitary tract] neurons. To address the issue of whether GLP-1R agonists applied systemically directly access central GLP-1 receptors, Rinaman showed some images of brain regions with GLP-1 receptors and the axons of GLP-1 neurons labeled in different colors (Farkas et al., 2021)
Our approach starting low and increasing gradually minimizes this
This may include people who: Are early in treatment Recently changed their dose Already have nausea, vomiting, reflux, diarrhea, or constipation Have trouble staying hydrated Have diabetes or take blood sugar-lowering medication Have a history of pancreatitis Have gallbladder disease or gallstones Have liver disease or abnormal liver enzymes Drink heavily or binge drink Have a history of alcohol use disorder Are pregnant, trying to become pregnant, or breastfeeding Are taking other medications that interact with alcohol If any of these apply to you, do not guess
doi: 10.2337/DC22-1148 [DOI] [PubMed] [Google Scholar] 65.Pasternak B, Wintzell V, Hviid A, et al
J.NianC.McIntoshC
